Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells

• Published in: Nature communications Vol. 12; no. 1; p. 3350
• Main Authors: Cifarelli, Vincenza, Appak-Baskoy, Sila, Peche, Vivek S., Kluzak, Andrew, Shew, Trevor, Narendran, Ramkumar, Pietka, Kathryn M., Cella, Marina, Walls, Curtis W., Czepielewski, Rafael, Ivanov, Stoyan, Randolph, Gwendalyn J., Augustin, Hellmut G., Abumrad, Nada A.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.06.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 14; 631/80/86; 692/163/2743/393; 692/699/317; Adipose tissue; AKT protein; Cadherins; Capillaries; CD36 antigen; Clonal deletion; Deletion; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Endothelial cells; Genetic diversity; Genetic variance; Glucose; Glucose tolerance; Humanities and Social Sciences; Inflammation; Insulin; Insulin resistance; Integrity; Intolerance; Lipids; Metabolic disorders; Metabolic syndrome; multidisciplinary; Obesity; Phenotypes; Phosphorylation; Resistance factors; Risk analysis; Risk factors; Science; Science (multidisciplinary); Vascular endothelial growth factor
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-021-23808-3

Disruption of lymphatic lipid transport is linked to obesity and type 2 diabetes (T2D), but regulation of lymphatic vessel function and its link to disease remain unclear. Here we show that intestinal lymphatic endothelial cells (LECs) have an increasing CD36 expression from lymphatic capillaries (lacteals) to collecting vessels, and that LEC CD36 regulates lymphatic integrity and optimizes lipid transport. Inducible deletion of CD36 in LECs in adult mice ( Cd36 ΔLEC ) increases discontinuity of LEC VE-cadherin junctions in lacteals and collecting vessels. Cd36 ΔLEC mice display slower transport of absorbed lipid, more permeable mesenteric lymphatics, accumulation of inflamed visceral fat and impaired glucose disposal. CD36 silencing in cultured LECs suppresses cell respiration, reduces VEGF-C-mediated VEGFR2/AKT phosphorylation and destabilizes VE-cadherin junctions. Thus, LEC CD36 optimizes lymphatic junctions and integrity of lymphatic lipid transport, and its loss in mice causes lymph leakage, visceral adiposity and glucose intolerance, phenotypes that increase risk of T2D. Genetic variants in CD36 have been associated with metabolic syndrome. Here, the authors found that lymphatic vessel integrity and lipid transport are influenced by CD36 expression, and lymphatic endothelial cell CD36 deficiency causes visceral obesity and insulin resistance, which are risk factors for metabolic syndrome and diabetes.